The first Arrowhead Pharmaceuticals trade was made in Q2 2016.
Since then Steven Cohen bought shares eight more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -811 shares
Q4 2023
Avg closing price
$26.56
Price range
$21.20
-
$31.03
Sold 10.7% shares (-97 shares)
Q3 2023
Avg closing price
$30.63
Price range
$26.20
-
$36.08
New holding (+908 shares)
Q2 2023
Avg closing price
$34.48
Price range
$25.16
-
$41.38
Sold -56.7 Thousand shares
Q1 2023
Avg closing price
$31.45
Price range
$23.68
-
$38.51
Sold 91.5% shares (-610 Thousand shares)
Q4 2022
Avg closing price
$33.13
Price range
$28.00
-
$40.56
Increased shares by 68.4% (+271 Thousand shares)
Q3 2022
Avg closing price
$40.36
Price range
$29.63
-
$48.31
Sold 29.4% shares (-165 Thousand shares)
Q2 2022
Avg closing price
$37.62
Price range
$27.79
-
$50.61
Increased shares by 1166.8% (+517 Thousand shares)
Q1 2022
Avg closing price
$49.51
Price range
$39.62
-
$69.97
Sold 72.4% shares (-116 Thousand shares)
Q4 2021
Avg closing price
$68.71
Price range
$58.09
-
$82.51
Increased shares by 187.1% (+105 Thousand shares)
Q3 2021
Avg closing price
$64.75
Price range
$58.38
-
$84.96
New holding (+55.9 Thousand shares)
Q2 2021
Avg closing price
$74.45
Price range
$62.15
-
$90.32
Sold -1.33 Million shares
Q4 2020
Avg closing price
$63.95
Price range
$43.82
-
$85.37
Increased shares by 12.0% (+143 Thousand shares)
Q3 2020